McNeil voluntarily recalls more Tylenol
McNeil Consumer Healthcare, a unit of Johnson & Johnson, is voluntarily recalling nearly 128,000 bottles of Tylenol 8-hour caplets after some consumers complained of a musty or moldy odor in the products, the company announced.
McNeil Consumer Healthcare, a unit of Johnson & Johnson, is voluntarily recalling nearly 128,000 bottles of Tylenol 8-hour caplets after some consumers complained of a musty or moldy odor in the products, the company announced.
The recall involves 50-count bottles of Tylenol caplets manufactured in March at the company’s now temporarily shuttered Fort Washington, Pa., plant, said company spokeswoman Carol Goodrich, the New York Times reported. McNeil believes the odor in these products was caused by trace amounts of the same chemical that was to blame for product contamination at the Puerto Rico plant, she told the New York Times.
It is the latest in a series of recalls made by McNeil during the past year, involving more than 150 million units of Tylenol, Motrin, Benadryl, and Zyrtec for adults, infants, and children. The company temporarily closed the Fort Washington plant in May for an upgrade as a result of the recalls.
The House Committee on Oversight and Government Reform and FDA’s Office of Criminal Investigation are separately investigating McNeil’s conduct surrounding the recalls.
Psychiatric Pharmacist Working to Optimize Treatment, Improve Patient Safety
December 13th 2024A conversation with Nina Vadiei, PharmD, BCPP, clinical associate professor in the Division of Pharmacotherapy at University of Texas at Austin College of Pharmacy and a clinical pharmacy specialist in psychiatry at the San Antonio State Hospital.
